RNTX
Rein Therapeutics Inc
0.7484$
+0.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | |
| – | -28.6% | -44.4% | +69.0% | -28.9% | +5.2% | -25.8% | +39.7% | -29.6% | -47.1% | -98.4% | |
| – | +9.9% | +154.2% | +87.5% | -35.5% | -10.5% | +19.4% | -7.8% | -42.9% | -6.1% | +99.1% | |
| – | +192.0% | -50.1% | +8.4% | +126.1% | -250.6% | – | +73.6% | -1,381.2% | – | -135.9% | |
| – | -100.0% | – | +3,014.8% | -96.6% | -96.7% | +3,040.0% | -100.0% | – | – | – | |
| – | -100.2% | +155,548.0% | – | -111.4% | – | -660.2% | – | -38.8% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +58.2% | -95.0% | +852.8% | -34.1% | +252.3% | -100.0% | – | +12.8% | -45.3% | |
| – | – | -152.2% | – | – | – | -331.4% | – | +660.3% | -136.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.